Pharmaceutical

Why can’t the US figure out weight loss drug prices?

Compounded GLP-1RAs have completely disrupted pricing frameworks for Wegovy and ...

Navigating uncertainty: the future of vaccine oversight...

The evolving landscape of vaccine oversight makes it key to maintain public trus...

BioCity’s SC0062 gains NMPA breakthrough therapy design...

The CDE of China's NMPA has granted BioCity's endothelin receptor type A (ETA) a...

Innovation in Focus: Highlights from the Two-Day London...

The London Biotechnology Show 2025, held from 18 to 19 June, encompassed a range...

UK steps up with £1.25bn Gavi vaccine pledge as US fund...

International vaccine group Gavi raised over $9bn, short of an $11.9bn target it...

Eli Lilly receives FDA approval for Amyvid label update

The US FDA has granted approval for a label update to Eli Lilly and Company's Am...

How AI and machine learning are transforming drug disco...

Drug discovery has traditionally been slow, expensive and prone to failure, but ...

Novartis concludes Regulus Therapeutics acquisition

Novartis has completed its previously announced acquisition of Regulus Therapeut...

Gilead eyes Kymera’s ‘adhesive’ cancer drug in $750m deal

Kymera’s programme focuses on removing CDK2 from cells compared to other therapi...

Porton Advanced and EVA Pharma collaborate for CAR T-ce...

Porton Advanced Solutions and EVA Pharma have signed an MoU to enhance the devel...

Vor Bio back from brink with autoimmune drug deal risin...

Equipped with a new CEO, Vor Bio is transitioning into an autoimmune player, lea...

FDA approves AstraZeneca and Daiichi Sankyo’s Datroway ...

The FDA has approved AstraZeneca and Daiichi Sankyo's Datroway (Datopotamab deru...

FDA genAI reviews hinge on clarity of dossiers

The FDA's new genAI-assisted scientific review technology, named Elsa, was offic...

Zambon gains Chinese regulatory authority approval for ...

Zambon Pharma has received approval from Chinese regulatory authorities and laun...

Navamedic signs agreement to acquire dne pharma

Navamedic has signed an agreement for the acquisition of Norwegian company dne p...